Skip to main content
impaact logo Return to homepage
  • Contact
    • Directory
  • About
    • Mission
    • Network Structure
      • Leadership
    • Areas of Research
      • Cure & Immunotherapy
      • Brain & Mental Health
      • Therapeutics
      • Tuberculosis
      • Social Behavioral Scientific Core (SBSC)
    • Early Career Investigator Program
    • Staff Spotlights
    • Funding Acknowledgements
    • Network Sites
      • Study Site Map
  • Studies
    • Research and Study Opportunities
    • Submit a Research Proposal
    • IMPAACT Study Snapshots
  • Community Engagement
    • ICAB Leadership Group
    • IMPAACT Community Advisory Board (ICAB)
    • Operations Center Staff
    • Resources
      • Acronyms
    • Site Community Advisory Boards
    • Community Meetings and Webinars
  • News & Events
    • Events and Conferences
    • IMPAACT Annual Meeting
    • Newsletters
    • Past Conference Presentations
    • Spotlight Series
  • Resources
    • COVID-19 Resources
    • HIV/AIDS Network Coordination (HANC)
    • Lab Center
      • Laboratory Committees
      • Laboratory Guidance Documents
      • Laboratory Resources for Quality Management
      • MiLab Resources
      • Specimen Repository
    • Manual of Procedures
    • Media Release Form
    • Network Logos & Templates
    • Regulatory Resources
    • Training Opportunities
    • NIH Updates
  • Publications
    • Abstracts
    • Manuscripts
  • Enter a search term.
Back to Directory

Karin Klingman

Email

kklingman@niaid.nih.gov

Phone

301-435-3772

Institution

Division of AIDS

Title

Medical Officer

Address

Division of AIDS
NIH, NIAID, DAIDS, TRP, HIVRB
MSC 7624, Room 5106
6700-B Rockledge Drive
Bethesda, MD 20892-7624
United States of America
Request an Update

Affiliated Studies

P1084s: Maternal Infant TDF Toxicity Safety

DAIDS Number

10790

Research Area

Therapeutics

Study Status

Closed to Follow Up

P1036B: Directly Observed Therapy in HIV-Infected Adolescents

DAIDS Number

10044

Research Area

Other

Study Status

Concluded

A5241: Identifying Salvage Regimen w/ & w/o NRTIs Using cPSS and New Agents in the US

DAIDS Number

10395

Research Area

Antiretroviral Strategies

Study Status

Concluded

1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival)

DAIDS Number

10779

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

1077FF: PROMISE 1077FF

DAIDS Number

10778

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed
IMPAACT logo Return to homepage

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.

Stay connected with the IMPAACT Network

Follow IMPAACT

Sign up for our newsletter

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Sitemap Privacy Notice

© 2020 IMPAACT Network